Welcome to our dedicated page for Imax SEC filings (Ticker: IMAX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IMAX Corporation (NYSE: IMAX) files reports and disclosure documents with the U.S. Securities and Exchange Commission that provide detail on its entertainment technology business, capital structure, and material events. These SEC filings include current reports on Form 8-K, annual and quarterly reports, and other documents that describe the company’s convertible notes, credit facilities, and operating results.
Among its recent filings, IMAX has reported the entry into a Seventh Amended and Restated Credit Agreement, which increased its revolving borrowing capacity and set out leverage covenants, guarantees, and use of proceeds. The company has also filed an 8-K describing the issuance of 0.75% convertible senior notes due 2030, outlining interest terms, maturity, conversion rights, redemption conditions, and related capped call transactions intended to reduce potential dilution or offset certain cash payments upon conversion.
Investors reviewing IMAX filings can use this page to access documents that discuss the company’s financial obligations, including convertible debt, revolving credit facilities, and related covenants. Filings also reference IMAX’s global footprint, with systems operating in multiple countries and territories, and its listing on the New York Stock Exchange under the symbol IMAX.
Stock Titan’s SEC filings page for IMAX provides real-time access to new submissions from the EDGAR system, along with AI-powered summaries designed to explain the key terms and implications of complex filings. Users can quickly identify items related to financing transactions, results of operations, and other material corporate developments, and can locate information relevant to topics such as note conversion features, redemption provisions, and reporting covenants.
Nomura Asset Management International Inc. and Nomura Investment Management Business Trust report beneficial ownership of 4,267,949 IMAX Corp common shares, representing 7.9% of the class. The stake is held with shared voting and dispositive power, and no sole voting or dispositive authority.
The firms state the IMAX shares were acquired and are held in the ordinary course of business, not to change or influence control of the company. The ownership percentage is based on 53,798,934 common shares outstanding as of September 30, 2025, as disclosed in IMAX’s Form 10-Q.
Orbis Investment Management Limited and Allan Gray Australia Pty Ltd report beneficial ownership of 5,151,721 IMAX Corp common shares, representing 9.6% of the class as of December 31, 2025.
Orbis holds 5,131,901 shares and Allan Gray 19,820 shares, each with sole voting and dispositive power over its block. Other persons have rights to receive dividends and sale proceeds on these securities. Both firms state the shares were acquired and are held in the ordinary course of business, not to change or influence control of IMAX. They are classified as non‑U.S. institutions equivalent to investment advisers and certify their foreign regulatory regimes are substantially comparable to U.S. standards.
Macquarie Group Limited and related entities filed an amended Schedule 13G reporting that they no longer beneficially own any Imax Corp common shares. As of 12/31/2025, Macquarie Group Limited, Macquarie Management Holdings Inc., and Macquarie Investment Management Business Trust each report 0 shares with 0.00% of the class.
The filing shows no sole or shared voting or dispositive power for any of the reporting persons, confirming that their ownership has fallen to 5 percent or less of Imax’s common shares. The firms also certify that any prior holdings were in the ordinary course of business and not for influencing control of Imax.
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 3,435,348.37 shares of IMAX Corporation common stock, representing 6.4% of the class as of 12/31/2025. FMR has sole voting power over 3,432,291 shares and sole dispositive power over 3,435,348.37 shares.
Abigail P. Johnson is also reported as a beneficial owner of the same 3,435,348.37 shares, with sole dispositive power and no voting power. The securities are certified as acquired and held in the ordinary course of business, not for the purpose of changing or influencing control of IMAX.
IMAX Corporation’s major shareholder group has updated its ownership disclosure in an Amendment No. 10 to Schedule 13D. Kevin Douglas reports beneficial ownership of 8,885,073 IMAX common shares, representing 16.5% of the company, based on 53,798,934 shares outstanding as of September 30, 2025. His wife, Michelle Douglas, reports 6,509,439 shares, or 12.1%, and James E. Douglas, III reports 1,363,645 shares, or 2.5%.
The filing details how these holdings are spread across multiple California trusts and Celtic Financial LLC, including the K&M Douglas Trust with 3,862,346 shares and several irrevocable descendant trusts each holding 646,110 or 646,111 shares. It explains that Kevin and Michelle Douglas act as co‑trustees on several of these entities and that Kevin Douglas manages Celtic Financial LLC, which holds 571,989 shares. The amendment also notes that the filers have not executed any IMAX share transactions in the last 60 days.
IMAX Corporation chief executive officer and director Richard L. Gelfond reported multiple equity transactions on January 2, 2026 involving IMAX common shares and restricted share units. Vested restricted share units were converted into common shares at an exercise price of $0.00, and a portion of those shares was withheld at a price of $36.02 per share to cover related tax obligations. Following these transactions, Mr. Gelfond beneficially owns 635,940 IMAX common shares directly, along with outstanding equity awards consisting of 1,818,695 options and 231,562 restricted share units. The restricted share units are scheduled to vest in installments through January 2, 2029, each unit representing the right to receive one IMAX common share.
Seller Mark Welton has filed a notice of proposed sale of 25000 Class A common shares of IMAX on the NYSE through Merrill Lynch, with an aggregate market value of 982000. The issuer had 53798934 Class A common shares outstanding.
The securities to be sold were acquired on 03/07/2025 via vesting of 18234 RSUs and 6766 PSUs recorded as compensation, with payment dated 03/07/2025. During the past three months, Welton has already sold 49504 Class A common shares, generating gross proceeds of 1743926.91.
IMAX Corp officer Mark Welton, President IMAX Global Theatres, reported a sale of 25,000 common shares on 12/15/2025 at $39.28 per share. The sale was made pursuant to a Rule 10b5-1 Plan dated September 15, 2025.
After this transaction, he beneficially owns 128,323 common shares, and his remaining restricted share unit balance is 70,609.
IMAX Corporation executive Robert D. Lister, the Chief Legal Officer and Senior Executive Vice President, reported a charitable transfer of company stock. On December 11, 2025, he gifted 2,000 common shares of IMAX Corporation to a donor-advised fund, with the shares to be used for charitable purposes. The Form 4 shows the transaction at a price of $0.00, reflecting that this was a gift rather than a sale.
Following this transaction, Mr. Lister beneficially owns 159,421 common shares and holds 70,609 restricted share units. The filing notes that the timing of the gift relates to changes in tax regulations affecting charitable donations that take effect on January 1, 2026.
An affiliate of IMAX has filed a Form 144 notice covering the planned sale of 2,652 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $95,864.23. The filing notes that these common shares were acquired on 11/24/2025 by exercising stock options under a registered plan, with payment made in cash on the same date. The notice also reports that 53,798,934 common shares were outstanding at the time referenced.